Diagnosis of myasthenia gravis
RT Rousseff - Journal of clinical medicine, 2021 - mdpi.com
The diagnosis of autoimmune Myasthenia Gravis (MG) remains clinical and rests on the
history and physical findings of fatigable, fluctuating muscle weakness in a specific …
history and physical findings of fatigable, fluctuating muscle weakness in a specific …
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
R Iorio - Nature Reviews Neurology, 2024 - nature.com
Myasthenia gravis (MG) is an autoimmune disorder that affects the neuromuscular junction,
leading to muscle weakness and fatigue. MG is caused by antibodies against the …
leading to muscle weakness and fatigue. MG is caused by antibodies against the …
Impact of COVID-19 in AChR myasthenia gravis and the safety of vaccines: data from an Italian cohort
A Lupica, V Di Stefano, S Iacono, A Pignolo… - Neurology …, 2022 - mdpi.com
Background and aims. Patients with Myasthenia gravis (MG) are considered vulnerable as
they may present with respiratory muscle weakness and because they are on …
they may present with respiratory muscle weakness and because they are on …
Diagnosis and treatment of myasthenia gravis
R Mantegazza, P Cavalcante - Current opinion in rheumatology, 2019 - journals.lww.com
CBAs can lead to a significant reduction of seronegative patients, improving myasthenia
gravis diagnostic process. New biological drugs offer innovative approaches to treat …
gravis diagnostic process. New biological drugs offer innovative approaches to treat …
Practical approach to respiratory emergencies in neurological diseases
F Racca, A Vianello, T Mongini, P Ruggeri… - Neurological …, 2020 - Springer
Many neurological diseases may cause acute respiratory failure (ARF) due to involvement of
bulbar respiratory center, spinal cord, motoneurons, peripheral nerves, neuromuscular …
bulbar respiratory center, spinal cord, motoneurons, peripheral nerves, neuromuscular …
Diagnosis and management of myasthenia gravis
MK Hehir, Y Li - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
Diagnosis and Management of Myasthenia Gravis : CONTINUUM: Lifelong Learning in
Neurology Account Register Activate Subscription Help Subscribe American Academy of …
Neurology Account Register Activate Subscription Help Subscribe American Academy of …
Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal
A Meisel, F Baggi, A Behin, A Evoli… - European Journal of …, 2023 - Wiley Online Library
Background and purpose Although myasthenia gravis (MG) is recognized as an
immunoglobulin G autoantibody‐mediated disease, the relationship between autoantibody …
immunoglobulin G autoantibody‐mediated disease, the relationship between autoantibody …
Benefit and danger from immunotherapy in myasthenia gravis
C Rodolico, G Nicocia, V Damato, G Antonini… - Neurological …, 2021 - Springer
In the last years, significant advances have improved the knowledge of myasthenia gravis
(MG) immunopathogenesis and have enabled to realize new molecules with a selective …
(MG) immunopathogenesis and have enabled to realize new molecules with a selective …
Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy
G Antonini, F Habetswallner, M Inghilleri… - Heliyon, 2023 - cell.com
The purpose of this study was to investigate the epidemiology, management, and economic
burden of myasthenia gravis in settings of real clinical practice. The analysis used …
burden of myasthenia gravis in settings of real clinical practice. The analysis used …
Autoimmune channelopathies at neuromuscular junction
K Huang, YB Luo, H Yang - Frontiers in Neurology, 2019 - frontiersin.org
The neuromuscular junction, also called myoneural junction, is a site of chemical
communication between a nerve fiber and a muscle cell. There are many types of channels …
communication between a nerve fiber and a muscle cell. There are many types of channels …